These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17951225)

  • 21. Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research.
    Kozma CM; Reeder CE; Schulz RM
    Clin Ther; 1993; 15(6):1121-32; discussion 1120. PubMed ID: 8111809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials.
    Buchanan DR; O'Mara AM; Kelaghan JW; Sgambati M; McCaskill-Stevens W; Minasian L
    Cancer; 2007 Oct; 110(7):1621-8. PubMed ID: 17868120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT.
    Valdagni R; Rancati T; Fiorino C; Fellin G; Magli A; Baccolini M; Bianchi C; Cagna E; Greco C; Mauro FA; Monti AF; Munoz F; Stasi M; Franzone P; Vavassori V
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1065-73. PubMed ID: 18234449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient-reported outcomes in phase II cancer clinical trials: lessons learned and future directions.
    Wagner LI; Wenzel L; Shaw E; Cella D
    J Clin Oncol; 2007 Nov; 25(32):5058-62. PubMed ID: 17991921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of palliative care in the lung cancer patient: can we improve quality while limiting futile care?
    Freedman OC; Zimmermann C
    Curr Opin Pulm Med; 2009 Jul; 15(4):321-6. PubMed ID: 19436207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
    Bottomley A; Jones D; Claassens L
    Eur J Cancer; 2009 Feb; 45(3):347-53. PubMed ID: 19013787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based outcomes in pain research and clinical practice.
    Gatchel RJ; Theodore BR
    Pain Pract; 2008; 8(6):452-60. PubMed ID: 19000173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do general dimensions of quality of life add clinical value to symptom data?
    Moinpour CM; Donaldson GW; Redman MW
    J Natl Cancer Inst Monogr; 2007; (37):31-8. PubMed ID: 17951229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial.
    Nout RA; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Stenfert Kroese MC; van Bunningen BN; Smit VT; Nijman HW; van den Tol PP; Creutzberg CL
    J Clin Oncol; 2009 Jul; 27(21):3547-56. PubMed ID: 19546404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of quality of life in men with prostate cancer.
    Albaugh J; Hacker ED
    Clin J Oncol Nurs; 2008 Feb; 12(1):81-6. PubMed ID: 18258577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of care: the use of conceptual models to "see the forest and the trees" in planning outcomes studies.
    Camann MA
    Top Health Inf Manage; 2001 Nov; 22(2):10-4. PubMed ID: 11761787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
    Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
    J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Funding patient-reported outcomes in cancer clinical trials.
    Moinpour CM; Denicoff AM; Bruner DW; Kornblith AB; Land SR; O'Mara A; Trimble E
    J Clin Oncol; 2007 Nov; 25(32):5100-5. PubMed ID: 17991928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The patient-reported outcome (PRO) consortium: filling measurement gaps for PRO end points to support labeling claims.
    Coons SJ; Kothari S; Monz BU; Burke LB
    Clin Pharmacol Ther; 2011 Nov; 90(5):743-8. PubMed ID: 21993428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome measures of specific immunotherapy.
    Pfaar O; Anders C; Klimek L
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):208-13. PubMed ID: 19365259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RTOG clinical trials for prostate cancer.
    DeMare PA
    Hawaii Med J; 2007 Oct; 66(10):273-4, 276. PubMed ID: 18065125
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical practice and patients' health status: how are the two related?
    Wilson IB; Kaplan S
    Med Care; 1995 Apr; 33(4 Suppl):AS209-14. PubMed ID: 7723449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation oncology research in the cancer and leukemia group B.
    Bogart JA; Seagren SL; Glicksman A
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3628s-34s. PubMed ID: 16740797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.